Skip to main content
Top
Published in: European Journal of Medical Research 1/2023

Open Access 01-12-2023 | Stevens-Johnson Syndrome | Review

Photodistributed Stevens–Johnson syndrome and toxic epidermal necrolysis: a systematic review and proposal for a new diagnostic classification

Authors: Blake Jeffrey McKinley, Mitchell Edger Allen, Nicole Michels

Published in: European Journal of Medical Research | Issue 1/2023

Login to get access

Abstract

Background

Ultraviolet radiation (UVR) exposure is commonly reported as a risk factor for Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). However, minimal evaluation of photo-induced SJS/TEN has been conducted. Thus, this review identifies all cases of SJS/TEN that are linked to an acute exposure of UVR and outlines the unifying characteristics of these cases. Furthermore, the theoretical pathogenesis, differential diagnoses, and proposed diagnostic criteria are defined.

Methods

PubMed, Google Scholar, and other databases and websites were searched from inception to September 2021 to identify studies that met inclusion criteria. The following keywords were utilized: “Stevens-Johnson syndrome” and “toxic epidermal necrolysis” with “ultraviolet,” “photodistributed,” “photo-induced,” “photosensitivity,” and “photo.” One reviewer assessed study characteristics, with confirmation by a second. The risk of bias was assessed independently by another.

Results

Thirteen patient cases were identified, all reporting ultraviolet radiation prior to rash onset and an underlying causal drug. Case classifications included 7/13 SJS and 6/13 TEN. All cases described the rash as photodistributed with UVR exposure prior to rash onset (delay of 1–3 days) and a causal drug. 10 cases provided evidence that the photodistributed rash lacked linear demarcation (as in a sunburn) with satellite target-like lesions. No cases described a flu-like prodrome.

Discussion

Mucositis, palmar and plantar rash, a positive Nikolsky sign, and a prolonged disease course can help distinguish from photosensitive reactions, while a negative direct immunofluorescence test is important to distinguish from other photo-induced disorders.

Conclusion

Physicians should be aware that UVR may precipitate SJS/TEN in patients taking susceptible drugs. After a 24-h delay from UVR exposure, a non-distinct, photodistributed rash appears with no flu-like prodrome and progresses for at least 48 h to include vesiculobullous eruptions and mucous membrane involvement. Photodistributed SJS/TEN appears to be photo-drug-induced with a unique onset and rash presentation that should be recognized as a distinct diagnosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T. Current perspectives on Stevens-Johnson syandrome and toxic epidermal necrolysis. Clin Rev Allergy Immunol. 2018;54:147–76.PubMedCrossRef Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T. Current perspectives on Stevens-Johnson syandrome and toxic epidermal necrolysis. Clin Rev Allergy Immunol. 2018;54:147–76.PubMedCrossRef
2.
go back to reference Dodiuk-Gad RP, Chung W-H, Valeyrie-Allanore L, Shear NH. Stevens-Johnson syndrome and toxic epidermal necrolysis: an update. Am J Clin Dermatol. 2015;16:475–93.PubMedCrossRef Dodiuk-Gad RP, Chung W-H, Valeyrie-Allanore L, Shear NH. Stevens-Johnson syndrome and toxic epidermal necrolysis: an update. Am J Clin Dermatol. 2015;16:475–93.PubMedCrossRef
3.
go back to reference Liotti L, Caimmi S, Bottau P, Bernardini R, Cardinale F, Saretta F, et al. Clinical features, outcomes and treatment in children with drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis. Acta Biomed. 2019;90:52–60.PubMed Liotti L, Caimmi S, Bottau P, Bernardini R, Cardinale F, Saretta F, et al. Clinical features, outcomes and treatment in children with drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis. Acta Biomed. 2019;90:52–60.PubMed
6.
go back to reference Yoshida S. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. In: Mahmoudi M, editor. Challenging cases in allergic and immunologic diseases of the skin. New York, NY: Springer; 2010. Yoshida S. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. In: Mahmoudi M, editor. Challenging cases in allergic and immunologic diseases of the skin. New York, NY: Springer; 2010.
7.
go back to reference Kohanim S, Palioura S, Saeed HN, Akpek EK, Amescua G, Basu S, et al. Stevens-Johnson syndrome/toxic epidermal necrolysis–a comprehensive review and guide to therapy. I Systemic Disease Ocul Surf. 2016;14:2–19.PubMedCrossRef Kohanim S, Palioura S, Saeed HN, Akpek EK, Amescua G, Basu S, et al. Stevens-Johnson syndrome/toxic epidermal necrolysis–a comprehensive review and guide to therapy. I Systemic Disease Ocul Surf. 2016;14:2–19.PubMedCrossRef
8.
go back to reference Gisondi P, Piaserico S, Bordin C, Bellinato F, Tozzi F, Alaibac M, et al. The safety profile of hydroxychloroquine: major cutaneous and extracutaneous adverse events. Clin Exp Rheumatol. 2021;39:1099–107.PubMedCrossRef Gisondi P, Piaserico S, Bordin C, Bellinato F, Tozzi F, Alaibac M, et al. The safety profile of hydroxychloroquine: major cutaneous and extracutaneous adverse events. Clin Exp Rheumatol. 2021;39:1099–107.PubMedCrossRef
10.
go back to reference Fritsch PO, Sidoroff A. Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. Am J Clin Dermatol. 2000;1:349–60.PubMedCrossRef Fritsch PO, Sidoroff A. Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. Am J Clin Dermatol. 2000;1:349–60.PubMedCrossRef
11.
go back to reference Calogiuri G, Garvey LH, Nettis E, Romita P, Di Leo E, Caruso R, et al. Skin allergy to azole antifungal agents for systemic use: a review of the literature. Recent Pat Inflamm Allergy Drug Discov. 2019;13:144–57.PubMedCrossRef Calogiuri G, Garvey LH, Nettis E, Romita P, Di Leo E, Caruso R, et al. Skin allergy to azole antifungal agents for systemic use: a review of the literature. Recent Pat Inflamm Allergy Drug Discov. 2019;13:144–57.PubMedCrossRef
14.
go back to reference Cac NN, Messingham MJ, Sniezek PJ, Walling HW. Stevens-Johnson syndrome induced by doxycycline. Cutis. 2007;79:119–22.PubMed Cac NN, Messingham MJ, Sniezek PJ, Walling HW. Stevens-Johnson syndrome induced by doxycycline. Cutis. 2007;79:119–22.PubMed
15.
go back to reference Kulkarni M, Saxena R, Diaczok B, Nassif H. Tetracycline re-exposure-induced toxic epidermal necrolysis. Am J Ther. 2019;26:e745–7.PubMedCrossRef Kulkarni M, Saxena R, Diaczok B, Nassif H. Tetracycline re-exposure-induced toxic epidermal necrolysis. Am J Ther. 2019;26:e745–7.PubMedCrossRef
16.
go back to reference Gunawardane ND, Menon K, Guitart J, Cotliar JA. Purpura fulminans from meningococcemia mimicking Stevens-Johnson syndrome in an adult patient taking etanercept. Arch Dermatol. 2012;148:1429–31.PubMedCrossRef Gunawardane ND, Menon K, Guitart J, Cotliar JA. Purpura fulminans from meningococcemia mimicking Stevens-Johnson syndrome in an adult patient taking etanercept. Arch Dermatol. 2012;148:1429–31.PubMedCrossRef
17.
go back to reference Kumar V, Gari M, Chakraborty K, Ranjan R, Chandra A, Kumari K. Nimesulide induced toxic epidermal necrolysis: a rare case report. Int J Basic Clin Pharmacol. 2017;6:2939–42.CrossRef Kumar V, Gari M, Chakraborty K, Ranjan R, Chandra A, Kumari K. Nimesulide induced toxic epidermal necrolysis: a rare case report. Int J Basic Clin Pharmacol. 2017;6:2939–42.CrossRef
18.
go back to reference Witharana EWRA, Wijetunga WMG, a. STB, Wijesinghe SKJ,. Stevens—Johnson syndrome (SJS) following Murunga leaf (Moringa oleifera) consumption. Ceylon Med J. 2018;63:188–9.PubMedCrossRef Witharana EWRA, Wijetunga WMG, a. STB, Wijesinghe SKJ,. Stevens—Johnson syndrome (SJS) following Murunga leaf (Moringa oleifera) consumption. Ceylon Med J. 2018;63:188–9.PubMedCrossRef
19.
go back to reference Peermohamed S, Haber RM. Acute generalized exanthematous pustulosis simulating toxic epidermal necrolysis: a case report and review of the literature. Arch Dermatol. 2011;147:697–701.PubMedCrossRef Peermohamed S, Haber RM. Acute generalized exanthematous pustulosis simulating toxic epidermal necrolysis: a case report and review of the literature. Arch Dermatol. 2011;147:697–701.PubMedCrossRef
20.
22.
go back to reference Redondo P, Vicente J, España A, Subira ML, De Felipe I, Quintanilla E. Photo-induced toxic epidermal necrolysis caused by clobazam. Br J Dermatol. 1996;135:999–1002.PubMedCrossRef Redondo P, Vicente J, España A, Subira ML, De Felipe I, Quintanilla E. Photo-induced toxic epidermal necrolysis caused by clobazam. Br J Dermatol. 1996;135:999–1002.PubMedCrossRef
23.
go back to reference Ting W, Stone MS, Racila D, Scofield RH, Sontheimer RD. Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus and the spectrum of the acute syndrome of apoptotic pan-epidermolysis (ASAP): a case report, concept review and proposal for new classification of lupus erythematosus vesiculobullous skin lesions. Lupus. 2004;13:941–50.PubMedCrossRef Ting W, Stone MS, Racila D, Scofield RH, Sontheimer RD. Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus and the spectrum of the acute syndrome of apoptotic pan-epidermolysis (ASAP): a case report, concept review and proposal for new classification of lupus erythematosus vesiculobullous skin lesions. Lupus. 2004;13:941–50.PubMedCrossRef
24.
go back to reference Lee HY, Tey HL, Pang SM, Thirumoorthy T. Systemic lupus erythematosus presenting as Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of three cases. Lupus. 2011;20:647–52.PubMedCrossRef Lee HY, Tey HL, Pang SM, Thirumoorthy T. Systemic lupus erythematosus presenting as Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of three cases. Lupus. 2011;20:647–52.PubMedCrossRef
25.
go back to reference Yildirim Cetin G, Sayar H, Ozkan F, Kurtulus S, Kesici F, Sayarlioglu M. A case of toxic epidermal necrolysis-like skin lesions with systemic lupus erythematosus and review of the literature. Lupus. 2013;22:839–46.PubMedCrossRef Yildirim Cetin G, Sayar H, Ozkan F, Kurtulus S, Kesici F, Sayarlioglu M. A case of toxic epidermal necrolysis-like skin lesions with systemic lupus erythematosus and review of the literature. Lupus. 2013;22:839–46.PubMedCrossRef
26.
go back to reference Jang HW, Shin JJ, Park JB, Son SW. Stevens-Johnson Syndrome-like skin lesions in a patient with juvenile systemic lupus erythematosus. Ann Dermatol. 2016;28:117–8.PubMedPubMedCentralCrossRef Jang HW, Shin JJ, Park JB, Son SW. Stevens-Johnson Syndrome-like skin lesions in a patient with juvenile systemic lupus erythematosus. Ann Dermatol. 2016;28:117–8.PubMedPubMedCentralCrossRef
27.
go back to reference Romero LS, Bari O, Forbess Smith CJ, Schneider JA, Cohen PR. Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: report of a case and review of the literature. Dermatol Online J. 2018;24:13030/qt5r79d67k.PubMedCrossRef Romero LS, Bari O, Forbess Smith CJ, Schneider JA, Cohen PR. Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: report of a case and review of the literature. Dermatol Online J. 2018;24:13030/qt5r79d67k.PubMedCrossRef
28.
go back to reference Ortel B, Sivayathorn A, Hönigsmann H. An unusual combination of phototoxicity and Stevens-Johnson syndrome due to antimalarial therapy. Dermatologica. 1989;178:39–42.PubMedCrossRef Ortel B, Sivayathorn A, Hönigsmann H. An unusual combination of phototoxicity and Stevens-Johnson syndrome due to antimalarial therapy. Dermatologica. 1989;178:39–42.PubMedCrossRef
29.
go back to reference Suárez Moro R, Trapiella Martínez L, Avanzas González E, Salas Puig J, Fernández Fernández C. Stevens-Johnson syndrome secondary to carbamazepine mediated by photosensitivity. An Med Interna. 2000;17:105–6.PubMed Suárez Moro R, Trapiella Martínez L, Avanzas González E, Salas Puig J, Fernández Fernández C. Stevens-Johnson syndrome secondary to carbamazepine mediated by photosensitivity. An Med Interna. 2000;17:105–6.PubMed
30.
go back to reference Borrás-Blasco J, Navarro-Ruiz A, Matarredona J, Devesa P, Montesinos-Ros A, González-Delgado M. Photo-induced Stevens-Johnson syndrome due to sulfasalazine therapy. Ann Pharmacother. 2003;37:1241–3.PubMedCrossRef Borrás-Blasco J, Navarro-Ruiz A, Matarredona J, Devesa P, Montesinos-Ros A, González-Delgado M. Photo-induced Stevens-Johnson syndrome due to sulfasalazine therapy. Ann Pharmacother. 2003;37:1241–3.PubMedCrossRef
31.
go back to reference Mansur AT, Aydingöz IA. A case of toxic epidermal necrolysis with lesions mostly on sun-exposed skin. Photodermatol Photoimmunol Photomed. 2005;21:100–2.PubMedCrossRef Mansur AT, Aydingöz IA. A case of toxic epidermal necrolysis with lesions mostly on sun-exposed skin. Photodermatol Photoimmunol Photomed. 2005;21:100–2.PubMedCrossRef
32.
go back to reference Callaly EL, FitzGerald O, Rogers S. Hydroxychloroquine-associated, photo-induced toxic epidermal necrolysis. Clin Exp Dermatol. 2008;33:572–4.PubMedCrossRef Callaly EL, FitzGerald O, Rogers S. Hydroxychloroquine-associated, photo-induced toxic epidermal necrolysis. Clin Exp Dermatol. 2008;33:572–4.PubMedCrossRef
33.
go back to reference Huang H-T, Chang C-L, Tzeng D-S. Toxic epidermal necrolysis after sun-exposure probably due to lamotrigine and chlorpromazine. Asian J Psychiatr. 2010;3:240–2.PubMedCrossRef Huang H-T, Chang C-L, Tzeng D-S. Toxic epidermal necrolysis after sun-exposure probably due to lamotrigine and chlorpromazine. Asian J Psychiatr. 2010;3:240–2.PubMedCrossRef
34.
go back to reference Gatson NT, Travers JB, Al-Hassani M, Warren SJP, Hyatt A-M, Travers JB. Progression of toxic epidermal necrolysis after tanning bed exposure. Arch Dermatol. 2011;147:719–23.PubMedPubMedCentralCrossRef Gatson NT, Travers JB, Al-Hassani M, Warren SJP, Hyatt A-M, Travers JB. Progression of toxic epidermal necrolysis after tanning bed exposure. Arch Dermatol. 2011;147:719–23.PubMedPubMedCentralCrossRef
35.
go back to reference Moghaddam S, Connolly D. Photo-induced Stevens-Johnson syndrome. J Am Acad Dermatol. 2014;71:e82-83.PubMedCrossRef Moghaddam S, Connolly D. Photo-induced Stevens-Johnson syndrome. J Am Acad Dermatol. 2014;71:e82-83.PubMedCrossRef
36.
go back to reference Eloranta K, Karakorpi H, Jeskanen L, Kluger N. Photo-distributed Stevens-Johnson syndrome associated with oral itraconazole. Int J Dermatol. 2016;55:e508-510.PubMedCrossRef Eloranta K, Karakorpi H, Jeskanen L, Kluger N. Photo-distributed Stevens-Johnson syndrome associated with oral itraconazole. Int J Dermatol. 2016;55:e508-510.PubMedCrossRef
37.
go back to reference Dean J, Biswas N, Robertson I. Photodistributed Stevens-Johnson syndrome associated with lamotrigine. Australas J Dermatol. 2018;59:32–129. Dean J, Biswas N, Robertson I. Photodistributed Stevens-Johnson syndrome associated with lamotrigine. Australas J Dermatol. 2018;59:32–129.
38.
go back to reference Russomanno K, DiLorenzo A, Horeczko J, Deng M, Cardis M, Petronic-Rosic V, et al. Photodistributed toxic epidermal necrolysis in association with lamotrigine and tanning bed exposure. JAAD Case Rep. 2021;14:68–71.PubMedPubMedCentralCrossRef Russomanno K, DiLorenzo A, Horeczko J, Deng M, Cardis M, Petronic-Rosic V, et al. Photodistributed toxic epidermal necrolysis in association with lamotrigine and tanning bed exposure. JAAD Case Rep. 2021;14:68–71.PubMedPubMedCentralCrossRef
39.
go back to reference McKinley BJ, Parkinson JS. Stevens-Johnson syndrome linked to tramadol use and ultraviolet radiation: a case report and literature review. Med Case Rep Study Protoc. 2021;2:e0176.CrossRef McKinley BJ, Parkinson JS. Stevens-Johnson syndrome linked to tramadol use and ultraviolet radiation: a case report and literature review. Med Case Rep Study Protoc. 2021;2:e0176.CrossRef
40.
go back to reference Sassolas B, Haddad C, Mockenhaupt M, Dunant A, Liss Y, Bork K, et al. ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis. Clin Pharmacol Ther. 2010;88:60–8.PubMedCrossRef Sassolas B, Haddad C, Mockenhaupt M, Dunant A, Liss Y, Bork K, et al. ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis. Clin Pharmacol Ther. 2010;88:60–8.PubMedCrossRef
42.
go back to reference Durbec F, Martin L, Derancourt C, Grange F. Melanoma of the hand and foot: epidemiological, prognostic and genetic features. A systematic review Br J Dermatol. 2012;166:727–39.PubMedCrossRef Durbec F, Martin L, Derancourt C, Grange F. Melanoma of the hand and foot: epidemiological, prognostic and genetic features. A systematic review Br J Dermatol. 2012;166:727–39.PubMedCrossRef
43.
44.
go back to reference Arellano J, Álvarez D, Salinas MP, Molina I, Arellano J, Álvarez D, et al. Incidencia de síndrome de Stevens-Johnson y necrólisis epidérmica tóxica en Chile años 2001–2015 y su asociación con latitud [Hospital discharges due to Stevens-Johnson syndrome and toxic epidermal necrolysis in Chile from 2001 to 2015]. Rev Med Chil. 2020;148:915–20.PubMedCrossRef Arellano J, Álvarez D, Salinas MP, Molina I, Arellano J, Álvarez D, et al. Incidencia de síndrome de Stevens-Johnson y necrólisis epidérmica tóxica en Chile años 2001–2015 y su asociación con latitud [Hospital discharges due to Stevens-Johnson syndrome and toxic epidermal necrolysis in Chile from 2001 to 2015]. Rev Med Chil. 2020;148:915–20.PubMedCrossRef
45.
go back to reference Goldman JL, Chung W-H, Lee BR, Chen C-B, Lu C-W, Hoetzenecker W, et al. Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement. Eur J Clin Pharmacol. 2019;75:1135–41.PubMedPubMedCentralCrossRef Goldman JL, Chung W-H, Lee BR, Chen C-B, Lu C-W, Hoetzenecker W, et al. Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement. Eur J Clin Pharmacol. 2019;75:1135–41.PubMedPubMedCentralCrossRef
46.
go back to reference Oakley AM, Krishnamurthy K. Stevens Johnson Syndrome. 2022 Aug 21. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 29083827. Oakley AM, Krishnamurthy K. Stevens Johnson Syndrome. 2022 Aug 21. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 29083827.
47.
go back to reference White KD, Chung W-H, Hung S-I, Mallal S, Phillips EJ. Evolving models of the immunopathogenesis of T cell-mediated drug allergy: the role of host, pathogens, and drug response. J Allergy Clin Immunol. 2015;136:219–34.PubMedPubMedCentralCrossRef White KD, Chung W-H, Hung S-I, Mallal S, Phillips EJ. Evolving models of the immunopathogenesis of T cell-mediated drug allergy: the role of host, pathogens, and drug response. J Allergy Clin Immunol. 2015;136:219–34.PubMedPubMedCentralCrossRef
48.
go back to reference Brockow K, Ardern-Jones MR, Mockenhaupt M, Aberer W, Barbaud A, Caubet J-C, et al. EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity. Allergy. 2019;74:14–27.PubMedCrossRef Brockow K, Ardern-Jones MR, Mockenhaupt M, Aberer W, Barbaud A, Caubet J-C, et al. EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity. Allergy. 2019;74:14–27.PubMedCrossRef
49.
go back to reference Contassot E, Gaide O, French LE. Death receptors and apoptosis. Dermatol Clin. 2007;25(487–501):vii.PubMed Contassot E, Gaide O, French LE. Death receptors and apoptosis. Dermatol Clin. 2007;25(487–501):vii.PubMed
50.
go back to reference Guerra KC, Zafar N, Crane JS. Skin Cancer Prevention. 2022 Aug 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 30137812. Guerra KC, Zafar N, Crane JS. Skin Cancer Prevention. 2022 Aug 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 30137812.
51.
go back to reference Bhardwaj SK, Singh H, Deep A, Khatri M, Bhaumik J, Kim K-H, et al. UVC-based photoinactivation as an efficient tool to control the transmission of coronaviruses. Sci Total Environ. 2021;792: 148548.PubMedPubMedCentralCrossRef Bhardwaj SK, Singh H, Deep A, Khatri M, Bhaumik J, Kim K-H, et al. UVC-based photoinactivation as an efficient tool to control the transmission of coronaviruses. Sci Total Environ. 2021;792: 148548.PubMedPubMedCentralCrossRef
52.
go back to reference Dubakiene R, Kupriene M. Scientific problems of photosensitivity. Medicina. 2006;42:619–24.PubMed Dubakiene R, Kupriene M. Scientific problems of photosensitivity. Medicina. 2006;42:619–24.PubMed
54.
go back to reference Hofmann GA, Weber B. Drug-induced photosensitivity: culprit drugs, potential mechanisms and clinical consequences. J Dtsch Dermatol Ges. 2021;19:19–29.PubMedPubMedCentral Hofmann GA, Weber B. Drug-induced photosensitivity: culprit drugs, potential mechanisms and clinical consequences. J Dtsch Dermatol Ges. 2021;19:19–29.PubMedPubMedCentral
56.
57.
go back to reference Monteiro AF, Rato M, Martins C. Drug-induced photosensitivity: Photoallergic and phototoxic reactions. Clin Dermatol. 2016;34:571–81.PubMedCrossRef Monteiro AF, Rato M, Martins C. Drug-induced photosensitivity: Photoallergic and phototoxic reactions. Clin Dermatol. 2016;34:571–81.PubMedCrossRef
58.
go back to reference Zuba EB, Koronowska S, Osmola-Mańkowska A, Jenerowicz D. Drug-induced photosensitivity. Acta Dermatovenerol Croat. 2016;24:55–64.PubMed Zuba EB, Koronowska S, Osmola-Mańkowska A, Jenerowicz D. Drug-induced photosensitivity. Acta Dermatovenerol Croat. 2016;24:55–64.PubMed
59.
go back to reference Lugović Mihić L, Bulat V, Situm M, Cavka V, Krolo I. Allergic hypersensitivity skin reactions following sun exposure. Coll Antropol. 2008;32(Suppl 2):153–7.PubMed Lugović Mihić L, Bulat V, Situm M, Cavka V, Krolo I. Allergic hypersensitivity skin reactions following sun exposure. Coll Antropol. 2008;32(Suppl 2):153–7.PubMed
61.
go back to reference Silva R, Machado A, Brandão M, Gonçalo S. Patch test diagnosis in carbamazepine erythroderma. Contact Dermatitis. 1986;15:254–5.PubMedCrossRef Silva R, Machado A, Brandão M, Gonçalo S. Patch test diagnosis in carbamazepine erythroderma. Contact Dermatitis. 1986;15:254–5.PubMedCrossRef
62.
go back to reference Terui T, Tagami H. Eczematous drug eruption from carbamazepine: coexistence of contact and photocontact sensitivity. Contact Dermatitis. 1989;20:260–4.PubMedCrossRef Terui T, Tagami H. Eczematous drug eruption from carbamazepine: coexistence of contact and photocontact sensitivity. Contact Dermatitis. 1989;20:260–4.PubMedCrossRef
63.
go back to reference Yasuda S, Mizuno N, Kawabe Y, Sakakibara S. Photosensitive lichenoid reaction accompanied by nonphotosensitive subacute prurigo caused by carbamazepine. Photodermatol. 1988;5:206–10.PubMed Yasuda S, Mizuno N, Kawabe Y, Sakakibara S. Photosensitive lichenoid reaction accompanied by nonphotosensitive subacute prurigo caused by carbamazepine. Photodermatol. 1988;5:206–10.PubMed
64.
go back to reference Ljunggren B, Bojs G. A case of photosensitivity and contact allergy to systemic tricyclic drugs, with unusual features. Contact Dermatitis. 1991;24:259–65.PubMedCrossRef Ljunggren B, Bojs G. A case of photosensitivity and contact allergy to systemic tricyclic drugs, with unusual features. Contact Dermatitis. 1991;24:259–65.PubMedCrossRef
65.
go back to reference Drucker AM, Rosen CF. Drug-induced photosensitivity: culprit drugs, management and prevention. Drug Saf. 2011;34:821–37.PubMedCrossRef Drucker AM, Rosen CF. Drug-induced photosensitivity: culprit drugs, management and prevention. Drug Saf. 2011;34:821–37.PubMedCrossRef
66.
go back to reference Matsuo I, Ozawa A, Niizuma K, Ohkido M. Lichenoid dermatitis due to chlorpromazine phototoxicity. Dermatologica. 1979;159:46–9.PubMedCrossRef Matsuo I, Ozawa A, Niizuma K, Ohkido M. Lichenoid dermatitis due to chlorpromazine phototoxicity. Dermatologica. 1979;159:46–9.PubMedCrossRef
67.
go back to reference Kim WB, Shelley AJ, Novice K, Joo J, Lim HW, Glassman SJ. Drug-induced phototoxicity: a systematic review. J Am Acad Dermatol. 2018;79:1069–75.PubMedCrossRef Kim WB, Shelley AJ, Novice K, Joo J, Lim HW, Glassman SJ. Drug-induced phototoxicity: a systematic review. J Am Acad Dermatol. 2018;79:1069–75.PubMedCrossRef
68.
go back to reference Horio T. Chlorpromazine photoallergy. coexistence of immediate and delayed type. Arch Dermatol. 1975;111:1469–71.PubMedCrossRef Horio T. Chlorpromazine photoallergy. coexistence of immediate and delayed type. Arch Dermatol. 1975;111:1469–71.PubMedCrossRef
69.
go back to reference Tolland JP, Murphy BP, Boyle J, Hall V, McKenna KE, Elborn JS. Ciprofloxacin-induced phototoxicity in an adult cystic fibrosis population. Photodermatol Photoimmunol Photomed. 2012;28:258–60.PubMedCrossRef Tolland JP, Murphy BP, Boyle J, Hall V, McKenna KE, Elborn JS. Ciprofloxacin-induced phototoxicity in an adult cystic fibrosis population. Photodermatol Photoimmunol Photomed. 2012;28:258–60.PubMedCrossRef
70.
go back to reference Momin N, Phan P, Ali AA, Ali I, H, Seeger CM, Joseph M,. Benzodiazepine-induced photosensitivity reactions: a compilation of cases from literature review with Naranjo causality assessment. Photodermatol Photoimmunol Photomed. 2021;37:505–10.PubMedCrossRef Momin N, Phan P, Ali AA, Ali I, H, Seeger CM, Joseph M,. Benzodiazepine-induced photosensitivity reactions: a compilation of cases from literature review with Naranjo causality assessment. Photodermatol Photoimmunol Photomed. 2021;37:505–10.PubMedCrossRef
71.
go back to reference Lisi P, Assalve D, Hansel K. Phototoxic and photoallergic dermatitis caused by hydroxychloroquine. Contact Dermatitis. 2004;50:255–6.PubMedCrossRef Lisi P, Assalve D, Hansel K. Phototoxic and photoallergic dermatitis caused by hydroxychloroquine. Contact Dermatitis. 2004;50:255–6.PubMedCrossRef
72.
go back to reference Cosa G, Lukeman M, Scaiano JC. How drug photodegradation studies led to the promise of new therapies and some fundamental carbanion reaction dynamics along the way. Acc Chem Res. 2009 May 19;42(5):599–607. https://doi.org/10.1021/ar8001969. PMID: 19320473. Cosa G, Lukeman M, Scaiano JC. How drug photodegradation studies led to the promise of new therapies and some fundamental carbanion reaction dynamics along the way. Acc Chem Res. 2009 May 19;42(5):599–607. https://​doi.​org/​10.​1021/​ar8001969. PMID: 19320473.
73.
go back to reference Bergner T, Przybilla B. Photosensitization caused by ibuprofen. J Am Acad Dermatol. 1992;26:114–6.PubMedCrossRef Bergner T, Przybilla B. Photosensitization caused by ibuprofen. J Am Acad Dermatol. 1992;26:114–6.PubMedCrossRef
74.
go back to reference Bignon E, Marazzi M, Besancenot V, Gattuso H, Drouot G, Morell C, et al. Ibuprofen and ketoprofen potentiate UVA-induced cell death by a photosensitization process. Sci Rep. 2017;7:8885.PubMedPubMedCentralCrossRef Bignon E, Marazzi M, Besancenot V, Gattuso H, Drouot G, Morell C, et al. Ibuprofen and ketoprofen potentiate UVA-induced cell death by a photosensitization process. Sci Rep. 2017;7:8885.PubMedPubMedCentralCrossRef
75.
go back to reference Alvarez-Fernández J, Castaño-Suárez E, Cornejo-Navarro P, Gómez de la Fuente E, Ortiz de Frutos F, Iglesias-Diez L. Photosensitivity induced by oral itraconazole. J Eur Acad Dermatol Venereol. 2000;14:501–3.PubMedCrossRef Alvarez-Fernández J, Castaño-Suárez E, Cornejo-Navarro P, Gómez de la Fuente E, Ortiz de Frutos F, Iglesias-Diez L. Photosensitivity induced by oral itraconazole. J Eur Acad Dermatol Venereol. 2000;14:501–3.PubMedCrossRef
77.
go back to reference Bilski PJ, Wolak MA, Zhang V, Moore DE, Chignell CF. Photochemical reactions involved in the phototoxicity of the anticonvulsant and antidepressant drug lamotrigine (Lamictal). Photochem Photobiol. 2009;85:1327–35.PubMedCrossRef Bilski PJ, Wolak MA, Zhang V, Moore DE, Chignell CF. Photochemical reactions involved in the phototoxicity of the anticonvulsant and antidepressant drug lamotrigine (Lamictal). Photochem Photobiol. 2009;85:1327–35.PubMedCrossRef
78.
go back to reference Diffey BL, Daymond TJ, Fairgreaves H. Phototoxic reactions to piroxicam, naproxen and tiaprofenic acid. Br J Rheumatol. 1983;22:239–42.PubMedCrossRef Diffey BL, Daymond TJ, Fairgreaves H. Phototoxic reactions to piroxicam, naproxen and tiaprofenic acid. Br J Rheumatol. 1983;22:239–42.PubMedCrossRef
79.
go back to reference Rojas Perez-Ezquerra P, Torrado-Español I, Tejero-Alcalde M, Cuevas-Bravo C, Noguerado-Mellado B. Photoallergy to Naproxen. Cureus. 2021;13: e18961.PubMedPubMedCentral Rojas Perez-Ezquerra P, Torrado-Español I, Tejero-Alcalde M, Cuevas-Bravo C, Noguerado-Mellado B. Photoallergy to Naproxen. Cureus. 2021;13: e18961.PubMedPubMedCentral
81.
go back to reference Moore DE. Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management. Drug Saf. 2002;25:345–72.PubMedCrossRef Moore DE. Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management. Drug Saf. 2002;25:345–72.PubMedCrossRef
82.
go back to reference Beberok A, Rzepka Z, Rok J, Banach K, Wrześniok D. UVA radiation enhances lomefloxacin-mediated cytotoxic, growth-inhibitory and pro-apoptotic effect in human melanoma cells through excessive reactive oxygen species generation. Int J Mol Sci. 2020;21:E8937.CrossRef Beberok A, Rzepka Z, Rok J, Banach K, Wrześniok D. UVA radiation enhances lomefloxacin-mediated cytotoxic, growth-inhibitory and pro-apoptotic effect in human melanoma cells through excessive reactive oxygen species generation. Int J Mol Sci. 2020;21:E8937.CrossRef
83.
go back to reference de Jager TL, Cockrell AE, Du Plessis SS. Ultraviolet light induced generation of reactive oxygen species. Adv Exp Med Biol. 2017;996:15–23.PubMedCrossRef de Jager TL, Cockrell AE, Du Plessis SS. Ultraviolet light induced generation of reactive oxygen species. Adv Exp Med Biol. 2017;996:15–23.PubMedCrossRef
84.
go back to reference Brand RM, Wipf P, Durham A, Epperly MW, Greenberger JS, Falo LD. Targeting mitochondrial oxidative stress to mitigate UV-induced skin damage. Front Pharmacol. 2018;9:920.PubMedPubMedCentralCrossRef Brand RM, Wipf P, Durham A, Epperly MW, Greenberger JS, Falo LD. Targeting mitochondrial oxidative stress to mitigate UV-induced skin damage. Front Pharmacol. 2018;9:920.PubMedPubMedCentralCrossRef
85.
go back to reference Abe R. Immunological response in Stevens-Johnson syndrome and toxic epidermal necrolysis. J Dermatol. 2015;42:42–8.PubMedCrossRef Abe R. Immunological response in Stevens-Johnson syndrome and toxic epidermal necrolysis. J Dermatol. 2015;42:42–8.PubMedCrossRef
86.
87.
go back to reference Sanchez DP, Sonthalia S. Koebner Phenomenon. 2022 Nov 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 31971748. Sanchez DP, Sonthalia S. Koebner Phenomenon. 2022 Nov 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 31971748.
88.
go back to reference Rodríguez-Pazos L, Gómez-Bernal S, Rodríguez-Granados MT, Toribio J. Photodistributed erythema multiforme. Actas Dermosifiliogr. 2013;104:645–53.PubMedCrossRef Rodríguez-Pazos L, Gómez-Bernal S, Rodríguez-Granados MT, Toribio J. Photodistributed erythema multiforme. Actas Dermosifiliogr. 2013;104:645–53.PubMedCrossRef
89.
go back to reference Middleton MH, Norris DA. Cytokine-induced ICAM-1 expression in human keratinocytes is highly variable in keratinocyte strains from different donors. J Invest Dermatol. 1995;104:489–96.PubMedCrossRef Middleton MH, Norris DA. Cytokine-induced ICAM-1 expression in human keratinocytes is highly variable in keratinocyte strains from different donors. J Invest Dermatol. 1995;104:489–96.PubMedCrossRef
90.
go back to reference Xu H, Guan H, Zu G, Bullard D, Hanson J, Slater M, et al. The role of ICAM-1 molecule in the migration of Langerhans cells in the skin and regional lymph node. Eur J Immunol. 2001;31:3085–93.PubMedPubMedCentralCrossRef Xu H, Guan H, Zu G, Bullard D, Hanson J, Slater M, et al. The role of ICAM-1 molecule in the migration of Langerhans cells in the skin and regional lymph node. Eur J Immunol. 2001;31:3085–93.PubMedPubMedCentralCrossRef
91.
go back to reference Bachmann MF, McKall-Faienza K, Schmits R, Bouchard D, Beach J, Speiser DE, et al. Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. Immunity. 1997;7:549–57.PubMedCrossRef Bachmann MF, McKall-Faienza K, Schmits R, Bouchard D, Beach J, Speiser DE, et al. Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. Immunity. 1997;7:549–57.PubMedCrossRef
92.
go back to reference Scholer A, Hugues S, Boissonnas A, Fetler L, Amigorena S. Intercellular adhesion molecule-1-dependent stable interactions between T cells and dendritic cells determine CD8+ T cell memory. Immunity. 2008;28:258–70.PubMedCrossRef Scholer A, Hugues S, Boissonnas A, Fetler L, Amigorena S. Intercellular adhesion molecule-1-dependent stable interactions between T cells and dendritic cells determine CD8+ T cell memory. Immunity. 2008;28:258–70.PubMedCrossRef
93.
go back to reference Köck A, Schwarz T, Kirnbauer R, Urbanski A, Perry P, Ansel JC, et al. Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med. 1990;172:1609–14.PubMedCrossRef Köck A, Schwarz T, Kirnbauer R, Urbanski A, Perry P, Ansel JC, et al. Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med. 1990;172:1609–14.PubMedCrossRef
94.
go back to reference De Maria R, Testi R. Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity. Immunol Today. 1998;19:121–5.PubMed De Maria R, Testi R. Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity. Immunol Today. 1998;19:121–5.PubMed
95.
go back to reference Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science. 1998;282:490–3.PubMedCrossRef Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science. 1998;282:490–3.PubMedCrossRef
96.
go back to reference Hill LL, Ouhtit A, Loughlin SM, Kripke ML, Ananthaswamy HN, Owen-Schaub LB. Fas ligand: a sensor for DNA damage critical in skin cancer etiology. Science. 1999;285:898–900.PubMedCrossRef Hill LL, Ouhtit A, Loughlin SM, Kripke ML, Ananthaswamy HN, Owen-Schaub LB. Fas ligand: a sensor for DNA damage critical in skin cancer etiology. Science. 1999;285:898–900.PubMedCrossRef
97.
go back to reference Bashir MM, Sharma MR, Werth VP. UVB and proinflammatory cytokines synergistically activate TNF-alpha production in keratinocytes through enhanced gene transcription. J Invest Dermatol. 2009;129:994–1001.PubMedCrossRef Bashir MM, Sharma MR, Werth VP. UVB and proinflammatory cytokines synergistically activate TNF-alpha production in keratinocytes through enhanced gene transcription. J Invest Dermatol. 2009;129:994–1001.PubMedCrossRef
98.
go back to reference Bang B, Rygaard J, Baadsgaard O, Skov L. Increased expression of Fas on human epidermal cells after in vivo exposure to single-dose ultraviolet (UV) B or long-wave UVA radiation. Br J Dermatol. 2002;147:1199–206.PubMedCrossRef Bang B, Rygaard J, Baadsgaard O, Skov L. Increased expression of Fas on human epidermal cells after in vivo exposure to single-dose ultraviolet (UV) B or long-wave UVA radiation. Br J Dermatol. 2002;147:1199–206.PubMedCrossRef
99.
go back to reference Paquet P, Jacob E, Damas P, Piérard GE. Treatment of drug-induced toxic epidermal necrolysis (Lyell’s syndrome) with intravenous human immunoglobulins. Burns. 2001;27:652–5.PubMedCrossRef Paquet P, Jacob E, Damas P, Piérard GE. Treatment of drug-induced toxic epidermal necrolysis (Lyell’s syndrome) with intravenous human immunoglobulins. Burns. 2001;27:652–5.PubMedCrossRef
100.
go back to reference Blakely KM, Drucker AM, Rosen CF. Drug-induced photosensitivity-an update: culprit drugs prevention and management. Drug Saf. 2019;42:827–47.PubMedCrossRef Blakely KM, Drucker AM, Rosen CF. Drug-induced photosensitivity-an update: culprit drugs prevention and management. Drug Saf. 2019;42:827–47.PubMedCrossRef
101.
go back to reference Yazici AC, Baz K, Ikizoglu G, Kokturk A, Uzumlu H, Tataroglu C. Celecoxib-induced photoallergic drug eruption. Int J Dermatol. 2004;43:459–61.PubMedCrossRef Yazici AC, Baz K, Ikizoglu G, Kokturk A, Uzumlu H, Tataroglu C. Celecoxib-induced photoallergic drug eruption. Int J Dermatol. 2004;43:459–61.PubMedCrossRef
102.
go back to reference Onoue S, Seto Y, Sato H, Nishida H, Hirota M, Ashikaga T, et al. Chemical photoallergy: photobiochemical mechanisms, classification, and risk assessments. J Dermatol Sci. 2017;85:4–11.PubMedCrossRef Onoue S, Seto Y, Sato H, Nishida H, Hirota M, Ashikaga T, et al. Chemical photoallergy: photobiochemical mechanisms, classification, and risk assessments. J Dermatol Sci. 2017;85:4–11.PubMedCrossRef
103.
go back to reference Balan RA, Lozneanu L, Grigoras A, Caruntu ID, Balan TA, Giusca SE, et al. Spongiotic reaction patterns in autoimmune bullous dermatoses (Review). Exp Ther Med. 2021;22:1334.PubMedPubMedCentralCrossRef Balan RA, Lozneanu L, Grigoras A, Caruntu ID, Balan TA, Giusca SE, et al. Spongiotic reaction patterns in autoimmune bullous dermatoses (Review). Exp Ther Med. 2021;22:1334.PubMedPubMedCentralCrossRef
105.
go back to reference Sameed M, Nwaiser C, Bhandari P, Schmalzle SA. Meropenem-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in a patient with known type IV penicillin hypersensitivity. BMJ Case Rep. 2019;12: e230144.PubMedPubMedCentralCrossRef Sameed M, Nwaiser C, Bhandari P, Schmalzle SA. Meropenem-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in a patient with known type IV penicillin hypersensitivity. BMJ Case Rep. 2019;12: e230144.PubMedPubMedCentralCrossRef
106.
go back to reference Yang L-P, Zhang A-L, Wang D-D, Ke H-X, Cheng Q, Wang C. Stevens-Johnson syndrome induced by the cross-reactivity between teicoplanin and vancomycin. J Clin Pharm Ther. 2014;39:442–5.PubMedCrossRef Yang L-P, Zhang A-L, Wang D-D, Ke H-X, Cheng Q, Wang C. Stevens-Johnson syndrome induced by the cross-reactivity between teicoplanin and vancomycin. J Clin Pharm Ther. 2014;39:442–5.PubMedCrossRef
107.
go back to reference Vivar KL, Mancl K, Seminario-Vidal L. Stevens-Johnson syndrome/toxic epidermal necrolysis associated with zonisamide. Clin Case Rep. 2018;6:258–61.PubMedCrossRef Vivar KL, Mancl K, Seminario-Vidal L. Stevens-Johnson syndrome/toxic epidermal necrolysis associated with zonisamide. Clin Case Rep. 2018;6:258–61.PubMedCrossRef
108.
go back to reference Balakirski G, Merk HF. Cutaneous allergic drug reactions: update on pathophysiology, diagnostic procedures and differential diagnosic. Cutan Ocul Toxicol. 2017;36:307–16.PubMedCrossRef Balakirski G, Merk HF. Cutaneous allergic drug reactions: update on pathophysiology, diagnostic procedures and differential diagnosic. Cutan Ocul Toxicol. 2017;36:307–16.PubMedCrossRef
109.
go back to reference Kojima T, Hasegawa T, Ishida H, Fujita M, Okamoto S. Griseofulvin-induced photodermatitis–report of six cases. J Dermatol. 1988;15:76–82.PubMedCrossRef Kojima T, Hasegawa T, Ishida H, Fujita M, Okamoto S. Griseofulvin-induced photodermatitis–report of six cases. J Dermatol. 1988;15:76–82.PubMedCrossRef
110.
go back to reference Correia O, Lomba Viana H, Azevedo R, Delgado L, Polónia J. Possible phototoxicity with subsequent progression to discoid lupus following pantoprazole administration. Clin Exp Dermatol. 2001;26:455–6.PubMedCrossRef Correia O, Lomba Viana H, Azevedo R, Delgado L, Polónia J. Possible phototoxicity with subsequent progression to discoid lupus following pantoprazole administration. Clin Exp Dermatol. 2001;26:455–6.PubMedCrossRef
111.
go back to reference Lamoreux MR, Sternbach MR, Hsu WT. Erythema multiforme. Am Fam Physician. 2006;74:1883–8.PubMed Lamoreux MR, Sternbach MR, Hsu WT. Erythema multiforme. Am Fam Physician. 2006;74:1883–8.PubMed
113.
go back to reference Schwartz RA, McDonough PH, Lee BW. Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis. J Am Acad Dermatol. 2013;69:173.e1-13.PubMedCrossRef Schwartz RA, McDonough PH, Lee BW. Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis. J Am Acad Dermatol. 2013;69:173.e1-13.PubMedCrossRef
114.
go back to reference Newkirk RE, Fomin DA, Braden MM. Erythema multiforme versus Stevens-Johnson syndrome/toxic epidermal necrolysis: subtle difference in presentation major difference in management. Mil Med. 2020;185:e1847–50.PubMedCrossRef Newkirk RE, Fomin DA, Braden MM. Erythema multiforme versus Stevens-Johnson syndrome/toxic epidermal necrolysis: subtle difference in presentation major difference in management. Mil Med. 2020;185:e1847–50.PubMedCrossRef
116.
go back to reference Mockenhaupt M. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. Expert Rev Clin Immunol. 2011;7:803–13.PubMedCrossRef Mockenhaupt M. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. Expert Rev Clin Immunol. 2011;7:803–13.PubMedCrossRef
117.
go back to reference Salmhofer W, Soyer HP, Wolf P, Födinger D, Hödl S, Kerl H. UV light-induced linear IgA dermatosis. J Am Acad Dermatol. 2004;50:109–15.PubMedCrossRef Salmhofer W, Soyer HP, Wolf P, Födinger D, Hödl S, Kerl H. UV light-induced linear IgA dermatosis. J Am Acad Dermatol. 2004;50:109–15.PubMedCrossRef
118.
go back to reference Jones DH, Todd M, Craig TJ. Early diagnosis is key in vancomycin-induced linear IgA bullous dermatosis and Stevens-Johnson syndrome. J Am Osteopath Assoc. 2004;104:157–63.PubMed Jones DH, Todd M, Craig TJ. Early diagnosis is key in vancomycin-induced linear IgA bullous dermatosis and Stevens-Johnson syndrome. J Am Osteopath Assoc. 2004;104:157–63.PubMed
119.
go back to reference Kridin K. Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations. Immunol Res. 2018;66:6–17.PubMedCrossRef Kridin K. Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations. Immunol Res. 2018;66:6–17.PubMedCrossRef
120.
121.
go back to reference Maynard B, Peters MS. Histologic and immunofluorescence study of cutaneous porphyrias. J Cutan Pathol. 1992;19:40–7.PubMedCrossRef Maynard B, Peters MS. Histologic and immunofluorescence study of cutaneous porphyrias. J Cutan Pathol. 1992;19:40–7.PubMedCrossRef
122.
go back to reference Velander MJ, Þorsteinsdóttir S, Bygum A. Clinical review of pseudoporphyria. Ugeskr Laeger. 2015;177:V11140599.PubMed Velander MJ, Þorsteinsdóttir S, Bygum A. Clinical review of pseudoporphyria. Ugeskr Laeger. 2015;177:V11140599.PubMed
123.
go back to reference Abdelmouttalib A, Meziane M, Senouci K. Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report. Pan Afr Med J. 2021;38:236.PubMedPubMedCentral Abdelmouttalib A, Meziane M, Senouci K. Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report. Pan Afr Med J. 2021;38:236.PubMedPubMedCentral
124.
go back to reference Sticherling M, Bonsmann G, Kuhn A. Diagnostic approach and treatment of cutaneous lupus erythematosus. J Dtsch Dermatol Ges. 2008;6:48–59.PubMedCrossRef Sticherling M, Bonsmann G, Kuhn A. Diagnostic approach and treatment of cutaneous lupus erythematosus. J Dtsch Dermatol Ges. 2008;6:48–59.PubMedCrossRef
125.
go back to reference Shelley WB, Shelley ED, Campbell AC, Weigensberg IJ. Drug eruptions presenting at sites of prior radiation damage (sunlight and electron beam). J Am Acad Dermatol. 1984;11:53–7.PubMedCrossRef Shelley WB, Shelley ED, Campbell AC, Weigensberg IJ. Drug eruptions presenting at sites of prior radiation damage (sunlight and electron beam). J Am Acad Dermatol. 1984;11:53–7.PubMedCrossRef
126.
go back to reference Najmi M, Sharp L, Tarbox M, Stetson C. Stevens-Johnson syndrome with a recall-like reaction within a donor graft site. Proc. 2020;34:85–6. Najmi M, Sharp L, Tarbox M, Stetson C. Stevens-Johnson syndrome with a recall-like reaction within a donor graft site. Proc. 2020;34:85–6.
127.
128.
go back to reference McCullough M, Burg M, Lin E, Peng D, Garner W. Steven Johnson syndrome and toxic epidermal necrolysis in a burn unit: A 15-year experience. Burns. 2017;43:200–5.PubMedCrossRef McCullough M, Burg M, Lin E, Peng D, Garner W. Steven Johnson syndrome and toxic epidermal necrolysis in a burn unit: A 15-year experience. Burns. 2017;43:200–5.PubMedCrossRef
130.
go back to reference Lissia M, Mulas P, Bulla A, Rubino C. Toxic epidermal necrolysis (Lyell’s disease). Burns. 2010;36:152–63.PubMedCrossRef Lissia M, Mulas P, Bulla A, Rubino C. Toxic epidermal necrolysis (Lyell’s disease). Burns. 2010;36:152–63.PubMedCrossRef
131.
go back to reference Sawada Y, Kabashima-Kubo R, Hino R, Nakamura M. Fatal case of toxic epidermal necrolysis caused by cefozopran and associated with psoriasis. Acta Derm Venereol. 2014;94:341–2.PubMedCrossRef Sawada Y, Kabashima-Kubo R, Hino R, Nakamura M. Fatal case of toxic epidermal necrolysis caused by cefozopran and associated with psoriasis. Acta Derm Venereol. 2014;94:341–2.PubMedCrossRef
133.
go back to reference Moniz P, Casal D, Mavioso C. Castro JV e, Almeida MA [Stevens-Johnson syndrome and toxic epidermal necrolysis: a 15-year retrospective study]. Acta Med Port. 2011;24:59–70.PubMedCrossRef Moniz P, Casal D, Mavioso C. Castro JV e, Almeida MA [Stevens-Johnson syndrome and toxic epidermal necrolysis: a 15-year retrospective study]. Acta Med Port. 2011;24:59–70.PubMedCrossRef
134.
go back to reference Ruocco E, Di Maio R, Caccavale S, Siano M, Lo SA. Radiation dermatitis, burns, and recall phenomena: meaningful instances of immunocompromised district. Clin Dermatol. 2014;32:660–9.PubMedCrossRef Ruocco E, Di Maio R, Caccavale S, Siano M, Lo SA. Radiation dermatitis, burns, and recall phenomena: meaningful instances of immunocompromised district. Clin Dermatol. 2014;32:660–9.PubMedCrossRef
135.
go back to reference Duncan KO, Tigelaar RE, Bolognia JL. Stevens-Johnson syndrome limited to multiple sites of radiation therapy in a patient receiving phenobarbital. J Am Acad Dermatol. 1999;40:493–6.PubMedCrossRef Duncan KO, Tigelaar RE, Bolognia JL. Stevens-Johnson syndrome limited to multiple sites of radiation therapy in a patient receiving phenobarbital. J Am Acad Dermatol. 1999;40:493–6.PubMedCrossRef
136.
go back to reference Sommers KR, Kong KM, Bui DT, Fruehauf JP, Holcombe RF. Stevens-Johnson syndrome/toxic epidermal necrolysis in a patient receiving concurrent radiation and gemcitabine. Anticancer Drugs. 2003;14:659–62.PubMedCrossRef Sommers KR, Kong KM, Bui DT, Fruehauf JP, Holcombe RF. Stevens-Johnson syndrome/toxic epidermal necrolysis in a patient receiving concurrent radiation and gemcitabine. Anticancer Drugs. 2003;14:659–62.PubMedCrossRef
137.
go back to reference Sarma N. Stevens-Johnson syndrome and toxic epidermal necrolysis overlap due to oral temozolomide and cranial radiotherapy. Am J Clin Dermatol. 2009;10:264–7.PubMedCrossRef Sarma N. Stevens-Johnson syndrome and toxic epidermal necrolysis overlap due to oral temozolomide and cranial radiotherapy. Am J Clin Dermatol. 2009;10:264–7.PubMedCrossRef
Metadata
Title
Photodistributed Stevens–Johnson syndrome and toxic epidermal necrolysis: a systematic review and proposal for a new diagnostic classification
Authors
Blake Jeffrey McKinley
Mitchell Edger Allen
Nicole Michels
Publication date
01-12-2023
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2023
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-023-01142-2

Other articles of this Issue 1/2023

European Journal of Medical Research 1/2023 Go to the issue